Stock 7760 IMV CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News IMV Corporation

Equities

7760

JP3100760002

Delayed Japan Exchange
Other stock markets
 11:30:00 04/07/2024 am IST 		5-day change 1st Jan Change
860 JPY +2.38% Intraday chart for IMV Corporation +8.72% +65.07%
09/04 Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. CI
25/03 BioVaxys Technology Plans Private Placement; Down 5.9% MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
CI
BioVaxys Technology Plans Private Placement; Down 5.9%
MT
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc.
MT
BioVaxys Acquires Entire Technology Portfolio Of The Former IMV Inc.
MT
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.
CI
IMV Corporation announces an Equity Buyback for 400,000 shares, representing 2.45% for ¥250 million.
CI
IMV Corporation authorizes a Buyback Plan.
CI
IMV Corporation Reports Earnings Results for the Full Year Ended September 30, 2023
CI
EKF Diagnostics hires CFO from Trellus Health, latter names successor
AN
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics
MT
Imv Corporation Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023
CI
Imv Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
CI
IMV Corporation Reports Earnings Results for the Half Year Ended March 31, 2023
CI
IMV Receives Delisting Notice From Nasdaq Over Bankruptcy Proceedings in Canada
MT
IMV Inc. Brief: Says Received NASDAQ Delisting Notice
MT
IMV Inc. Brief: Says Received Nasdaq Notification Regarding Minimum Bid Price Deficiency
MT
IMV Inc. Details Board Changes
MT
IMV Inc. Brief: Hall Adds Co engaged Stonegate to explore strategic alternatives, "So that MVP-S can realize its full clinical potential"
MT
IMV Inc. Brief: Andrew Hall, Chief Executive Officer, Said" "The market headwinds limiting available capital are, however, very real"
MT
IMV Inc. Brief: Net loss and comprehensive loss of US$38.0 million ($4.55 per share) for Year ended December 31, 2022, Vs net loss and comprehensive loss of $36.6 ($4.93 per share) for Year ended December 31, 2021
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 7760 Stock
  4. News IMV Corporation